Executive Officer Bios

John R. Plachetka, Pharm.D.

CEO John R. Plachetka, Pharm.D.John R. Plachetka, Pharm.D., is President, Chief Executive Officer and Chairman of the Board of Directors of POZEN. Prior to founding POZEN in 1996, Dr. Plachetka was Vice President of Development at Texas Biotechnology Corporation for two years, where he led the development of argatroban, a novel thrombin blocker. Previously, he served for two years as President and Chief Executive Officer of Clinical Research Foundation-America, a top-10 contract clinical research company in the U.S. This was preceded by a nine-year career at Glaxo Inc. where Dr. Plachetka held various executive positions including Director of Cardiovascular Clinical Research and led the U.S. development program for Imitrex®, Trandate®, and a thromboxane antagonist. He also participated in the development program for Zantac® tablets and injection.Dr. Plachetka was formerly assistant professor of Pharmacy Practice and Cardiovascular and Thoracic Surgery at the University of Arizona. He earned his bachelor’s degree in pharmacy from the University of Illinois College of Pharmacy and holds a doctor of pharmacy degree from the University of Missouri-Kansas City.

back to top

John G. Fort, M.D.

John G. Fort, M.D.John G. Fort, M.D. is Chief Medical Officer. Prior to joining POZEN, Dr. Fort was Vice President, Medical Affairs at Adolor Corporation and held positions with Pfizer Inc., including Vice President, Medical Affairs, and was Vice President, Arthritis and Pain at G.D. Searle & Co., Monsanto Corporation from September 1994 to December 2003. Prior to joining the pharmaceutical industry, he was an Associate Professor of Medicine at Thomas Jefferson University, Division of Rheumatology.Dr. Fort received his M.D. from the University of Valencia Faculty of Medicine and is board certified in internal medicine with a sub-specialty certification in rheumatology.

back to top

William L. Hodges

William L. Hodges, SVP, CFO POZENWilliam L. Hodges, CPA is Senior Vice President, Finance and Administration and Chief Financial Officer. Prior to joining the company in 2004, Mr. Hodges was Senior Vice President and Chief Financial Officer of Pergo, Inc., the leading U.S. laminate flooring manufacturer. Previously, he spent 16 years in the pharmaceutical industry, culminating as Senior Vice President and Chief Financial Officer at Glaxo Wellcome, Inc. He also worked four years as Vice President, Corporate Planning and Business Support at Glaxo Wellcome where he worked closely with the commercial and technical operations of the company. Mr. Hodges spent over two years in London, United Kingdom with Wellcome plc., where he served as Regional Controller – Northern Europe and Japan and Manager – Group Financial Analysis. At Burroughs Wellcome he held various financial management positions, including Director of Procurement, with responsibility for the U.S. and certain global operations.Mr. Hodges received his bachelor’s degree in Business Administration/Accounting from the University of North Carolina at Chapel Hill and is a certified public accountant.

back to top

Gilda M. Thomas

Gilda M. Thomas, SVP General Counsel, POZENGilda M. Thomas is Senior Vice President and General Counsel of POZEN. Prior to joining the company in 2007, Ms. Thomas was Vice President, General Counsel and company Secretary at EMD Pharmaceuticals, Inc., an affiliate of Merck KGaA, Darmstadt, Germany where she was responsible for overseeing and directing all legal matters for a fully-integrated start up pharmaceutical company. She spent 14 years at Burroughs Wellcome Co., which merged into Glaxo Welcome, Inc. At Glaxo Wellcome Ms. Thomas was Associate General Counsel responsible for the 13 member corporate section of the legal department.Ms. Thomas received a Juris Doctor degree from Harvard Law School, a masters’ degree from Simmons College and a bachelor’s degree from Wellesley College.

back to top

Dennis L. McNamara

Dennis L. McNamara is Senior Vice President, Chief Business Officer. Mr. McNamara joined POZEN in December 1998 as Vice President of Business  Development and held such positions through December 2013.  Prior to joining POZEN, Mr. McNamara held positions in business development with private and publicly-traded development stage biotechnology companies including AlphaVax, Sequana Therapeutics and Apex Bioscience, and in pharmaceutical sales with Abbott Laboratories.  Before joining the pharmaceutical industry Mr. McNamara conducted receptor pharmacology research at the University of North Carolina.  Mr. McNamara earned his M.B.A. from the University of Michigan  and an A.B. degree from Duke University.

back to top